Search
for
Sort by
Research 30 of 48
- Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- 067 BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- 068 Association of systemic involvement with skin morphology assessed by multiphoton microscopy in pseudoxanthoma elasticum
- Schmallenberg virus infection suspected in a calf born to an imported heifer
- Efficacy and safety of autologous hematopoietic stem cell transplantation in treating type 1 diabetes mellitus
- A rash diagnosis
- Severe Acute Respiratory Syndrome Among Children
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- No evidence for the immunocompetence handicap hypothesis in male humans
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Drug eruptions in dermatology
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss
- Quoi de neuf en recherche dermatologique ?
- Syphilis: today
- Amyopathic dermatomyositis presenting as severe alopecia and prominent eyelid edema: a case report and literature review
- NEW PROPRIETARY BRANDS: Gabapentin
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- NEW PROPRIETARY BRANDS: Cefaclor monohydrate
- NEW FORMULATIONS: Glatiramer acetate
- 13. Wound Healing & Hair
- 5. HIV, Fungal and Infectious Diseases
- 4. Bullous/Mucous Membrane
- 1. Medical Practice; Therapy; Adverse Reactions
- 12. Cancer